Merit Medical Systems Receives FDA Warning Letter Regarding Merit Laureate Hydrophilic Guidewire

by Matthew Kennedy, Benzinga Staff Writer

February 7, 2012 2:46 PM | 14 seconds read | Make a Comment

Merit Medical Systems, Inc.

MMSI

, today announced it received a warning letter from the U.S. Food and Drug Administration regarding modifications to the hydrophilic coating process for the Merit Laureate® Hydrophilic Guidewire after an inspection of the Company's facility in Galway, Ireland.

Market News and Data brought to you by Benzinga APIs

Posted In: News FDA

Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Merit Medical Systems Receives FDA Warning Letter Regarding Merit Laureate Hydrophilic Guidewire